John P. Butler
CEO, President at Akebia Therapeutics, Inc. (AKBA)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return-18.5%
vs. S&P 500-29.5%
Beat the market0%
Paper profit on buys−$31K
Total bought / sold$87K / $474K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 5SEC | AKBAAkebia Therapeutics, Inc. | Buy | 69,2703,367,064 held (+2%) | $1.25 | $87K | -35.9% |
| Feb 4SEC | AKBAAkebia Therapeutics, Inc. | Sell Plan | 46,6603,417,189 held (−1%) | $1.39 | $65K | -42.4% |
| Feb 4SEC | AKBAAkebia Therapeutics, Inc. | Sell Plan | 96,0653,321,124 held (−3%) | $1.39 | $134K | -42.4% |
| Feb 4SEC | AKBAAkebia Therapeutics, Inc. | Sell Plan | 114,8913,206,233 held (−3%) | $1.39 | $160K | -42.4% |
| Feb 4SEC | AKBAAkebia Therapeutics, Inc. | Sell Plan | 83,6893,297,794 held (−2%) | $1.39 | $116K | -42.4% |
- Buy
CEO, President John P. Butler bought $87K of AKBA at $1.25 — first open-market purchase in our records.
- Sell
CEO, President John P. Butler sold $65K of AKBA at $1.39 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President John P. Butler sold $134K of AKBA at $1.39 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President John P. Butler sold $160K of AKBA at $1.39 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President John P. Butler sold $116K of AKBA at $1.39 — pre-scheduled 10b5-1 plan sale.